We are live on ! Find out more
TRIV

TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV

Delisted

TRIV was delisted on the 3rd of February, 2016.

26 hedge funds and large institutions have $64.1M invested in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

19% less capital invested

Capital invested by funds: $79.6M → $64.1M (-$15.5M)

28% less funds holding

Funds holding: 3626 (-10)

83% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 12

Holders
26
Holders Change
-10
Holders Change %
-27.78%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
8
Reduced
6
Closed
12
Calls
Puts
Net Calls
Net Calls Change

TRIV Hedge Fund Activity: Q3 2015 in Review

26 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) for Q3 2015, worth a combined $64.1M — down 19% from $79.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of TRIV and 2 opened new positions — a net loss of 10 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Goldman Sachs, adding an estimated $387K. The largest seller was Stifel Financial, cutting an estimated $1.83M.

  • 26 institutional investors held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) as of Q3 2015, down from 36 in Q2 2015.
  • Funds reported $64.1M of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK stock for Q3 2015, down 19% quarter-over-quarter.
  • 2 funds opened new TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK positions in Q3 2015 and 12 closed out, a net change of -10 holders.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK buyer in Q3 2015 was Goldman Sachs, an estimated $387K added.
  • The largest TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK seller in Q3 2015 was Stifel Financial, an estimated $1.83M sold.

Based on aggregated 13F filings for Q3 2015.